H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.285 SGD -1.72% Market Closed
Market Cap: 88.1m SGD

Intrinsic Value

The intrinsic value of one 1J5 stock under the Base Case scenario is 0.461 SGD. Compared to the current market price of 0.285 SGD, Hyphens Pharma International Ltd is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

1J5 Intrinsic Value
0.461 SGD
Undervaluation 38%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hyphens Pharma International Ltd

1J5
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for 1J5 cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hyphens Pharma International Ltd
SGX:1J5
SG
Pharmaceuticals
Market Cap
88m SGD
IPO
May 18, 2018
SG
Pharmaceuticals
Market Cap
88m SGD
IPO
May 18, 2018
Price
S$false
EPS
S$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 1J5?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Hyphens Pharma International Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hyphens Pharma International Ltd

Current Assets 101.6m
Cash & Short-Term Investments 18.8m
Receivables 46m
Other Current Assets 36.8m
Non-Current Assets 30.2m
PP&E 5.1m
Intangibles 24.9m
Other Non-Current Assets 213k
Efficiency

Free Cash Flow Analysis
Hyphens Pharma International Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hyphens Pharma International Ltd

Revenue
195.4m SGD
Cost of Revenue
-125.9m SGD
Gross Profit
69.5m SGD
Operating Expenses
-54.3m SGD
Operating Income
15.2m SGD
Other Expenses
-5m SGD
Net Income
10.2m SGD
Fundamental Scores

1J5 Profitability Score
Profitability Due Diligence

Hyphens Pharma International Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROIC
Positive Gross Profit
Positive 3-Years Revenue Growth
Positive ROIC
59/100
Profitability
Score

Hyphens Pharma International Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

1J5 Solvency Score
Solvency Due Diligence

Hyphens Pharma International Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
High Altman Z-Score
82/100
Solvency
Score

Hyphens Pharma International Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

1J5 Price Targets Summary
Hyphens Pharma International Ltd

Wall Street analysts forecast 1J5 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1J5 is 0.357 SGD with a low forecast of 0.354 SGD and a high forecast of 0.368 SGD.

Lowest
Price Target
0.354 SGD
24% Upside
Average
Price Target
0.357 SGD
25% Upside
Highest
Price Target
0.368 SGD
29% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 1J5 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one 1J5 stock?

The intrinsic value of one 1J5 stock under the Base Case scenario is 0.461 SGD.

Is 1J5 stock undervalued or overvalued?

Compared to the current market price of 0.285 SGD, Hyphens Pharma International Ltd is Undervalued by 38%.

Back to Top